News-Papers
Testimonial
Video Gallery
Melatonin and its contribution to tumor attenuation in systemic malignancies
Published on Thursday, 14 August 2014
Letter To The Editor
See also About Melatonin.
Search
Follow us...
Latest
- Melatonin as an adjuvant in radiotherapy for radioprotection and radiosensitization
- Melatonin and cancer: From the promotion of genomic stability to use in cancer treatment
- Targeting Melatonin to Mitochondria Mitigates Castration-Resistant Prostate Cancer by Inducing Pyroptosis
- Estrogen-signaling pathway: a link between breast cancer and melatonin oncostatic actions
- Is Melatonin the "Next Vitamin D"?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements
- Programmed cell death and melatonin: A comprehensive review
- Beneficial properties of melatonin in an experimental model of pancreatic cancer
- Melatonin and breast cancer: cellular mechanisms, clinical studies and future perspectives
- Practical application of melatonin for pancreas disorders: protective roles against inflammation, malignancy, and dysfunctions
- Melatonin inhibits 17β-estradiol-induced migration, invasion and epithelial-mesenchymal transition in normal and endometriotic endometrial epithelial cells
- Melatonin for gastric cancer treatment: where do we stand?
- Melatonin: an inhibitor of breast cancer
- Vitamin D Supplementation During Neoadjuvant Chemotherapy for Breast Cancer Improves Pathological Complete Response: A Prospective Randomized Clinical Trial
- Vitamin D Supplementation Improves Pathological Complete Response in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy: A Randomized Clinical Trial
- Impact of vitamin D on pathological complete response and survival following neoadjuvant chemotherapy for breast cancer: a retrospective study
- Apoptotic effect of melatonin on ER-positive breast cancer cell lines: ADGRL4 gene expression and promoter methylation
- Mechanisms involved in the pro-apoptotic effect of melatonin in cancer cells
- Melatonin hybrids as multifunctional therapeutic agents: A comprehensive review
Most Read
- The Di Bella Method (DBM)
- About melatonin - 1996
- All-trans-retinoic acid and cancer
- Biography
- Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
- Somatostatin in oncology, the overlooked evidences
- The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
- Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
- Bibliography
- Complete objective response to biological therapy of plurifocal breast carcinoma
- How effective is chemo therapy?
- Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
- Vademecum
- Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
- Frequently Asked Questions
- Declaration recommends eliminate the use of Impact factor for research evaluation
- Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
- Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer